Overall, the findings of this study indicate that miR-372 is able to evoke migration and increase ROS via targeting of p62, which may decreases NQO1 expression then, and the circulatory miR-372 could be HNSCC tumor marker. This evidence concerns the gene NQO1 and head and neck squamous cell carcinoma.